Singh, Dave
Corradi, Massimo
Spinola, Monica
Petruzzelli, Stefano
Papi, Alberto
Article History
Received: 27 December 2015
Revised: 12 April 2016
Accepted: 22 April 2016
First Online: 16 June 2016
Competing interests
: D.S. has received sponsorship to attend and speak at international meetings, consultancy fees, honoraria for lecturing or attending advisory boards and research grants from various pharmaceutical companies including Almirall, AstraZeneca, Boehringer Ingelheim, Chiesi, Genentech, GlaxoSmithKline, Glenmark, Johnson and Johnson, Merck, NAPP, Novartis, Pfizer, Skypharma, Takeda, Teva, Therevance and Verona. M.C. has received honoraria for lecturing from Chiesi Farmaceutici. M.S. and S.P. are employees of Chiesi Farmaceutici. A.P. has received grants, personal fees and non-financial support from AstraZeneca, Chiesi Farmaceutici, GlaxoSmithKline, Boehringer Ingelheim, Merck Sharp & Dohme, Menarini, Novartis, Zambon, TEVA, Pfizer, Takeda and Mundipharma.